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Abstract
Regenerative medicine and dentistry are making an impact with successful clinical trials 
using stem cells. The discovery that dental tissues are one of the storehouses for stem 
cells and the fact that many health issues can be sorted out by the therapeutic application 
of stem cells, the emphasis and significance of understanding this vital subject is gaining 
vast importance. At this juncture, where Regenerative medicine is progressing to become 
“The Future,” this article hopes to focus in simple terms on the basics that every individual 
dentist has to know to deliver the utmost benefit to the profession and the society.
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Introduction
Regenerative medicine has become the order of the day due to 
the promise it offers for new therapeutic modalities, which aim 
at repairing and replacing tissues and organs that have lost its 
potential, due to disease, damage, genetic defects and ageing. 
Dental regenerative therapy opens an arena to provide living, 
functional, and biocompatible tissues.[1]
Tissues of the body (such as hematopoietic system, 
gastrointestinal system, dermal layers of skin) undergo rapid 
proliferation and were found to have the regenerative potential. 
This fact led to hypothesize that tissues, which regenerate 
may consist of cells that are responsible for the initialization of 
their replacement. These cells are the proposed “stem cells.”[2] 
Manipulation of these cells in vitro and using it for therapeutic 
purposes forms the basis for stem cell therapy.[3]
Stem cells offer a great promise in treatment for diseases, in 
screening of new drugs in research, to develop a replica to study 
normal growth and investigate the unique regenerative abilities 
of stem cells offer a lot of optimistic hope amongst scientific 
researchers, therapeutics, and most importantly to the patients 
who will be the chief beneficiary of this boon to science.
Two outstanding characteristics of stem cells make them 
unique [Figure 1].
1. Stem cells are unspecialized cells, which have the capacity to 
renew themselves for prolonged periods by cell division.
2. And they can be induced to transform into specialized 
cells with a specific function under certain physiological 
conditions.[4,5]
Stem cell classification falls under three main categories:
• Embryonic, germinal, and somatic[6,7]
Embryonic and Germinal Stem cells
Embryonic stem cells (ESCs) are extracted from 2 to 11 days 
old embryos that are the blastocysts. ESCs are found to originate 
from the inner cell mass of the blastocyst [Figure 2].[8-11]
ESCs are considered immortal. Their constant replicative 
life span can be attributed to their telomerase expression.[12] 
They can be propagated and maintained in an undifferentiated 
state indefinitely. Germinal stem cells are extracted from 
Figure 1: Stem cells have the capacity to renew themselves and 
they can be induced to transform into specialized cells with specific 
function
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primary germinal layers of the embryo. They can differentiate 
into progenitor cells and have the potential to produce specific 
organ cells. They are best grown from supernumerary embryos 
obtained from in vitro fertilization centers. ESCs are totipotent, 
and they have the most desired potential of regeneration and 
repair of diseased tissue and organs in the body.[13,14] However, 
drawbacks like moral and ethical concerns, difficulty to control 
the growth and differentiation of the ESC which leads to a risk 
of tumorogenicity and teratoma formation have led to ESCs 
not so far being used therapeutically and have only remained an 
excellent platform for research.[13-16]
Adult Stem Cells
Adult stem cells are present in the postnatal population. Adult 
stem cells are multipotent – capable of differentiating into more 
than one cell type but not all cell types. Their life span is less 
replicative than that of ESCs.
Mature tissues such as hematopoietic, gastrointestinal, neural, 
dental and other mesenchymal tissues demonstrate the presence 
of adult stem cells.[17-19] The plasticity of an adult stem cell is the 
ability of the stem cell to expand beyond its potential irrespective 
of the parent cell from which it is derived.[20] For example, dental 
pulp stem cells (DPSCs) not only develop into tooth tissue but 
also have the ability to differentiate into neuronal tissue.[21] 
Depending on where they originate, adult stem cells can be 
classified as hemopoietic stem cells, which are obtained from 
cord/peripheral blood and mesenchymal stem cells (MSCs).[22,23] 
which originate from the mesoderm layer and reside in a variety 
of adult tissues such as the bone marrow, limbal system, hepatic, 
dermal, dental tissues, etc.
Criterias proposed by the Mesenchymal and Tissue Stem Cell 
Committee of the International Society for Cellular Therapy can 
be considered as guidelines, which define human MSC.[24]
• MSC must continue to possess its property of plasticity when 
maintained in standard culture conditions.
• Cell surface markers - CD105, 73 and 90, have to be 
expressed, and expression of CD→ 45, 34,14, 11b, 79alpha or 
19 and HLA-DR surface molecules should be lacking.
• In vitro differentiation of MSC’s to osteoblasts, adipocytes 
and chondroblasts are considered necessary.
Induced pluripotent stem cells (iPSCs)
The development of iPSCs from adult stem cells showed that 
these somatic cells can be reprogrammed to adopt pluripotency 
by the enforced expression of a few embryonic transcription 
factors by retrovirus-mediated transduction [Figure 3].[25,26]
Takahashi and Yamanaka in 2006, practically derived iPSCs 
from embryonic and adult mouse fibroblasts by the ectopic-
coexpression of genes: Oct4, Sox2, Klf4, and c-Myc, which 
transformed the somatic cells to an ESC-like pluripotent state.[26] 
In dental tissues, human DPSCs showed promise with higher 
reprogramming efficiency and generated iPSCs much more than 
the conventionally used dermal fibroblasts and this can be attributed 
to high expression of endogenous reprogramming factors such 
as c-Myc and KLF4and/or ESC marker genes.[27,28] Because the 
DPSCs are easily accessible by dentist, iPSCs generated from 
dental tissues are expected to be a promising cell source for tissue 
regeneration. Using iPSCs for regenerative medicine has several 
advantages, the prominent one being that their use can overcome 
the ethical issues associated with the use of ESCs. iPs can also be 
used as autologous patient-specific cells and this eliminates the 
threat of immune rejection of the graft.[28] The bottlenecks of iPS 
are inadequate cell number and tumor (teratoma) formation.[29]
Stem Cell Markers
Literatures prove it difficult to expand certain types of adult stem 
cells in culture, unlike ESCs. Adult stem cells reside in specific 
organs and tissues, but they are very few in number, and they may 
be buried deep in organs and tissues and diffusely spread out. 
Under the microscope, stem cells look like any other cell in the 
body,[30] and hence markers are proposed for MSCs and they fall 
Figure 2: Embryonic stem cells are found to originate from the 
inner cell mass of the blastocyst
Figure 3: Somatic cells can be reprogrammed to adopt pluripotency 
by the enforced expression of a few embryonic transcription factors 
by retrovirus-mediated transduction
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into two categories: sole markers and stemness markers. A sole 
marker acts as a selection tool, which is sufficient to identify or 
purify MSC, which act by binding to unique receptors on the 
surface of the stem cell. Stro-1 is one of the most well-known 
markers for MSCs and is expressed in dental tissues,[30,31] synovial 
membrane, decidua parietalis-derived MSCs and multipotent 
dermal fibroblasts cell-surface glycoprotein on subsets Stro-1+ 
cells assists in isolating mesenchymal precursor cells (PCs).[30]
Regeneration of tooth/tooth related tissues
For tooth-related tissue regeneration, the pre-requisites are:
• Stem cells
• Signaling molecules that can trigger the differentiation of 
unspecialized stem cells into specialized cell types, i.e. into 
osteoblasts, odontoblasts, cementoblasts, fibroblasts, etc.
• Scaffold material which will act as a base to support and 
harvest cellular proliferation.
Research has led to identification of MSC-like cells in 
adipose tissue,[32] placenta,[33] synovial membrane,[34] peripheral 
blood,[35] endometrial tissues, umbilical cord, umbilical cord 
blood,[35] dental tissues etc.
The adult stem cell types that have been tried and explored in 
the arena of dentistry are:
• Bone marrow stem cells (BMSCs),
• Adipose tissue-derived stromal cells
• Dental stem cells.
BMSCs
The bone marrow stem cells form colony-forming unit-fibroblasts 
in vitro and are capable of differentiating into many types of cells 
of mesenchymal lineages (e.g. osteoblasts, adipocytes, muscle 
PCs, tenocytes, chondrocytes or neurogenic cells). Ohazama 
et al. published a report in 2004, proved that the generation of 
tooth-like structures was possible by culturing bone marrow-
derived cells in combination with embryonic oral epithelium in 
the renal capsule.[36] Similar results were demonstrated in a study 
conducted by Li et al. that the amalgamation of oral epithelial 
cells from rat embryos with BMSSCs resulted in the expression 
of variety odontogenic genes and histologically produced tooth-
like structures.[37]
Bone marrow stem cell implication in periodontal 
regeneration attracted a lot of attention when Kawaguch et al. 
in 2004 reported, after an animal study that auto-transplantation 
of these stem cells resulted in almost complete regeneration 
of periodontal defects in only four weeks and this was this was 
further confirmed histologically demonstrating cementum, 
periodontal ligament (PDL), and alveolar bone.[38]
Adipose-derived stromal cells (ADSCs)
ADSCs have a clear advantage of accessibility with minimally 
invasive methods and the tissue abundance, e.g. liposuction 
procedure. They satisfy the criteria of defined by Dominici et al. 
and exhibit a multilineage differentiation potential in vitro. Jing 
et al. in 2008 attempted biological replacement of lost teeth in 
elderly patients found ADSCs to be a good alternative for tooth 
and related tissue regeneration[39] as the Odontogenic capacity 
of BMSCs significantly decreases with increasing age of the 
donors.[40]
Dental stem cells
The most accessible stem cells are the dental stem cells. Stem 
cell-like qualities were found in certain cells derived from, dental 
pulp (DPSC), exfoliated deciduous teeth (stem cells from 
human exfoliated deciduous teeth [SHED]), PDL (PDL stem 
cell [PDLSC]), apical papilla (stem cells from apical papilla), and 
dental follicle (dental follicle progenitor cells)[41,42] [Figure 4].
Apart from regenerating dental tissues, biologically viable 
scaffolds can be used for the replacement of orofacial bone 
and cartilage, and defective salivary glands can be partially or 
completely regenerated.
Their capacity for self-renewal and potential for multilineage 
differentiation, as in osteogenic, chondrogenic, and adipogenic 
differentiation as well as regeneration of tooth-specific structures 
such as cementum have made them the most sought after group 
of stem cell source.
DPSCs
Gronthos et al. in 2000, were the first to successfully isolate 
stem cells from dental pulp (DPSCs), the experiment, which 
comprised of transplantation of these cells amalgamated with 
hydroxyapatite/tricalcium phosphate (HA/TCP) powder 
in an animal study (immune-compromised mice) showed 
formation of a structure mimicking dentin with odontblast-
like cells that surrounded a pulp-like interstitial tissue(pulp-
dentin complex).[43] The markers expressed by DPSCs are 
similar to those of MSCs could differentiate in vitro into other 
mesenchymal cell derivatives the list of which is given in Table 1.
Figure 4: Anatomical position of dental stem cell sources
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SHED
Miura et al. in 2003 identified dental pulp from deciduous teeth 
(SHED) as a good source of high-quality human postnatal stem 
cells. The results of the experiment demonstrated that SHED’s 
yield dentin and bone on combination with HA/TCP powder; 
however they did not form a dentin-pulp complex. They have 
good plasticity for multilineage differentiation in vitro [Table 1], 
show higher rates of proliferation and population doublings 
in comparison with stem cells of the dental pulp.[44].Cordeiro 
et al. (2008) suggested that SHEDs could be the ideal source of 
stem cells for repairing damaged teeth or for induction of bone 
formation.[45]
Stem cells from the apical papilla (SCAPs)
SCAPs are mostly found in the root apical papilla of third molars 
and teeth with open apices, i.e. developing teeth. The expression 
of surviving and telomerase, two important molecules in cell 
proliferation mediation, were found to be in high levels in these 
cells and this fact is attributed to the higher rates of proliferation 
in vitro compared with DPSCs.[46,47] SCAPs show a promising 
scope for cell-based therapy for root regeneration. Transplantation 
of these cells along with PDLSCs into tooth sockets of mini pigs 
demonstrated the formation of dentin and PDL.[47]
Dental follicle stem cells (DFSCs)
PCs for cementoblasts, osteoblasts, and PDL cells, were 
demonstrated by Morsczeck et al. in 2005 from the 
ectomesenchymal covering of the tooth follicles of developing 
third molars (DFSCs). These cells also exhibit multilineage 
differentiation as depicted in Table 1. In vivo they form 
cementum and PDL.[48]
Future treatment options for the restoration of damaged 
dentin, pulp, cementum and PDLs may make use of autologous 
stem cells such as DPSCs, SHEDs, SCAPs, and DFSCs that have 
been stored after removal from the patient.
Isolation and culture of DPSCs
In a study conducted by Perry et al. in 2008, the methodology 
used by researchers for successful isolation of stem cells from 
the dental pulp can be used as a reference for the technique 
protocol. The extraction should be performed with strict 
control of the aseptic chain. Soft tissue remnants to be removed 
and the teeth to be immediately transferred to sterile chilled 
vials containing 20 mL of either of the three collection/
transport solutions: Hypothermosol, mesencult basal medium 
or phosphate-buffered saline. Transportation of the teeth on 
ice to the laboratory is preferred. In the laboratory, External 
sterilization of the tooth by several washes in sterile phosphate-
buffered saline (PBS), followed by immersion in 1% povidone-
iodine for 2 min, immersion in 0.1% sodium thiosulfate in PBS 
for 1 min and another wash in sterile PBS is mandatory. The 
roots of cleaned teeth is then separated from the crown to reveal 
the dental pulp, and the extirpated pulp is to be placed into an 
enzymatic bath consisting of type I and type II collagenase with 
thermolysin as the neutral protease. In order to digest the tissue 
and liberate the cells, pulps should then be allowed to incubate 
at 37°C for 40 min. Once the digestion is complete, to neutralize 
the digestion enzymes mesencult complete medium should be 
added to a final volume of 1.5 times the digestion volume. The 
mixture should be then centrifuged at 500 g for 5 min, and the 
supernatant aspirated.
The cell pellet should then be re-suspended in fresh mesencult 
complete medium added with 0.25 μg/mL amphotericin B, 
100 IU/mL penicillin-G, and 100 μg/mL streptomycin. Cells 
should be plated at an initial concentration of one tooth digest 
per 25 cm2 flask. Culture flasks should be monitored daily and 
any contaminated flasks removed immediately and recorded. 
Non-contaminated flasks should be monitored for cell growth, 
three times per week. After 14 days of growth, DPSC can be 
detached using 0.25% trypsin/1 mmole EDTA.[49] The extracted 
cells are then cryopreserved for future use. This process 
of cryopreservation involves equilibrating the cells with a 
solvent - the cryoprotectant solution that prevents cells forming 
ice crystals. At the same time, the integrity of cell membranes is 
preserved and reversed to normal on thawing. Programmable 
controlled-rate freezers are utilized to slowly bring down the 
temperature to freezing. The cells that are frozen by this method 
are then transferred for long-term storage to vapor-phase 
liquid nitrogen freezers to be stored at ultra-low temperatures 
(−150°C).[50]
When the therapeutic need for these cells arises, 
reprogramming conditions/factors if required are introduced to 
induce self-renewal and pluripotency, with an aim of producing 
patient-specific iPSCs. Consecutive induction of these cells 
resultantly forms ectodermal epithelial cells and neural crest-
derived mesenchymal cells, which are further induced to form 
odontogenic cells in vitro. Combination by direct contact of 
both these cell populations, mimicking the in vivo arrangement 
provokes cellular interaction hence leading to the formation of 
an early-stage tooth germ. Once transplanted into the mouth, 
the recombinants develop and lead to functional recovery from 
tooth loss.
Scaffold is an extracellular matrix and mold to culture the 
stem cell and induce the desired function. Provides physical 
support to the cells required for regeneration of any tissue. The 
Table 1: Multilineage differentiating potential of dental stem cells
Stem cells from 
dental tissues
Multilineage differentiating potential
DPSCs Odontoblasts, adipocytes, chondrocytes, and 
osteoblasts and functionally active Neurons
SHEDs Neuron-like cells, odontoblasts, osteoblasts, 
and adipocytes
SCAPs Osteoblasts, odontoblasts, and adipocytes
DFSCs Osteoblasts, adipocytes , and nerve-like cells
DPSCs: Dental pulp stem cells, SHEDs: Stem cells from human exfoliated 
deciduous teeth, SCAPs: Stem cells from the apical papilla, DFSCs: Dental 
follicle stem cells
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ideal requirement of scaffolds is that it should be biodegradable, 
and rate of degradation should coincide with the rate of tissue 
formation. They should be porous and allow appropriate 
differentiation of cells causing no damage to the characters of 
the progeny. In the root canal, where the pulp has blood supply 
only from apical end system it is preferable to have a scaffold 
that promotes vascularization of the implanted cells and to 
promote angiogenesis, growth factors that favor angiogenesis 
are impregnated. As a result of advanced technologies like 
robotics assisted tissue-engineering, constructs can be prepared 
that have a controlled spatial distribution of cells and growth 
factors, as well as engineered gradients of scaffold materials with 
a predicted microstructure.[51]
Potential Applications in Medicine
Stem cells are being researched for a variety of chronic debilitating 
diseases that pose a therapeutic dilemma until date. Proposed 
cell therapy targets to repair, repopulate, and rewire tissues and 
organs with complete reversing of the pathology. In an experiment 
conducted by Seo et al. in 2009, SHEDs were successfully capable 
of repairing critical-size parietal defects in immunocompromised 
mice and they proposed a hypothesis that neural crest cell-derived 
SHED may offer optimal orofacial repairing with a matched 
neural crest origin.[52] Stem cells in cancer, according to a review 
by Sagar et al. in 2007, have expanded beyond its long-term usage 
for replenishment of blood and immune systems damaged by the 
cancer cells/chemotherapy/radiotherapy, but also to contribute 
in the tissue regeneration and as delivery vehicles in the cancer 
treatments.[53,54] 
DPSCs were proven to differentiate into functionally active 
neurons, and when implanted DPSCs induce endogenous 
axon guidance, suggesting their potential as cellular therapy 
for neuronal disorder. Thus, based on these findings, stem cell 
research has kindled hope in the field of medicine directed toward: 
brain damage, spinal cord injury, Parkinson’s disease, Alzheimer’s 
disease, amyotrophic lateral sclerosis, multiple sclerosis and other 
neurological and neurodegenerative disorders.[55] The Tissue 
regeneration concept hopes to repair heart damage, baldness, 
deafness, blindness, impaired vision, muscle damage, diabetes 
and related disorders, etc. Though not an established treatment 
yet, autologous hematopoietic stem cell therapy can induce 
remissions and even cure some selected patients with therapy-
refractory autoimmune diseases.[56] Stem cell research is a boon 
to drug research as the application of drugs directly to human 
cells, and this will provide more relevant data than testing on 
animal models.
Potential Applications in Dentistry
Cell-based therapy by intravenous injection and cell 
encapsulation system also has implications in dentistry, and 
stem cell research is directed towards achieving the following: 
Experiments in vitro and a few on animal models have regeneration 
of damaged coronal dentine and pulp, regeneration of resorbed 
root, cervical or apical dentin and perforations, periodontal 
regeneration, craniofacial defects by osteogenesis,[53] whole 
tooth regeneration[5] and treatment of oral mucosal lesions (oral 
submucous fibrosis, oral lichen planus, dyskeratosis congenita, 
premalignant lesions such as leukoplakia, recurrent oral ulcers, 
graft versus host disease and oral cancers).[57,58]
Conclusion
The isolation and understanding of dental stem cells and their 
multilineage differentiating potential combined with their easy 
accessibility has brought a new light to the field of dentistry, 
paving a path for the progressive evolution to “regenerative 
dentistry.” This changing concept and definition of a “dental 
caregiver” to a “regenerative dentist” with scope to “regrow” lost 
dental tissues is a boon from science as a biological solution to a 
biological problem.
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